✦ LIBER ✦

Validation of the German prostate-specific module

✍ Scribed by Beate Bestmann; Volker Rohde; Jens-Ulrich Siebmann; Razvan Galalae; Wolfgang Weidner; Thomas Küchler

Book ID: 106032973
Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 328 KB
Volume: 24
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-005-0023-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

QL5 VALIDATION OF THE GERMAN PROSTATE SP

QL5 VALIDATION OF THE GERMAN PROSTATE SPECIFIC MODULE (PSM)

✍ B Bestmann; V Rohde; W Weidner; T Kuechler 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Prostate-Specific Antigen Modulates the

Prostate-Specific Antigen Modulates the Expression of Genes Involved in Prostate Tumor Growth

✍ Bindukumar, B.; Schwartz, Stanley A.; Nair, Madhavan P.N.; Aalinkeel, Ravikumar; 📂 Article 📅 2005 🏛 Neoplasia Press 🌐 English ⚖ 265 KB

Prostate-specific antigen-based early de

Prostate-specific antigen-based early detection of prostate cancer—validation of screening without rectal examination

✍ Fritz H Schröder; Monique Roobol-Bouts; André N Vis; Theo van der Kwast; Ries Kr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Environmental tests of the GLAST validat

Environmental tests of the GLAST validation module calorimeter

✍ O. Ferreira; G. Bogaert; A. Bonnemaison; G. Drevillon; P. Fleury; B. Giebels; P. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 517 KB

German validation of the Conners Adult A

German validation of the Conners Adult ADHD Rating Scales (CAARS) II: Reliability, validity, diagnostic sensitivity and specificity

✍ H. Christiansen; B. Kis; O. Hirsch; S. Matthies; J. Hebebrand; J. Uekermann; M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 305 KB

Prostate-specific antigen: A review of t

Prostate-specific antigen: A review of the validation of the most commonly used cancer biomarker

✍ Javier Hernández; Ian M. Thompson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Abstract ## BACKGROUND The widespread use of prostate‐specific antigen (PSA) screening has had a tremendous impact on all aspects of the management of prostate carcinoma. Although PSA‐based screening has resulted in a stage migration to more organ‐confined tumors at the time of diagnosis, and h